CompletedNot Applicable

Effects of GLP-1 Agonists on Gastric Volume

United States210 participantsStarted 2023-08-09

Plain-language summary

This study will enroll patients ages 18 and over who have a diagnosis of diabetes, are undergoing an elective surgery under general anesthesia and 1) are taking a GLP-1 receptor agonist medication, or 2) not taking a GLP-1 receptor agonist medication. The patients will have a gastric ultrasound prior to surgery to measure any retained gastric contents. The primary goal is to assess the effect of subcutaneous injectable GLP-1 agonists on preoperative gastric volume in fasted, diabetic surgical patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria * Age greater than or equal to 18 years old * Diagnosed with diabetes (listed on medical record, Hgb A1C greater than or equal to 6.5%, fasting blood glucose greater than or equal to 126mg/dL, and/or on medical treatment for diabetes) * One of the following groups: * Taking a GLP-1 Medication * Not taking a GLP-1 Medication * ASA Physical Classification Status 1-3 * Scheduled for elective surgery under general anesthesia * Appropriately fasted per ASA Fasting Guidelines 201712 Exclusion Criteria * BMI greater than 40 * Previous gastric/esophageal surgery * Abnormal gastric anatomy * Pregnancy * Inability or unwillingness of subject to give informed consent * Non-English Speaking

What they're measuring

Gastric Volume in RLD Position

Timeframe: From time of enrollment until the start of surgery, assessed up to 4 weeks

Trial details

NCT IDNCT05854979

SponsorMedical University of South Carolina

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-04-15

View on ClinicalTrials.gov More Diabetes trials